Lonza and Bacthera presented during the Microbiome Connect: USA 2022 congress, last November in Boston, how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market. Felix Faupel, Chief Commercial Officer at Bacthera, discussed with Microbiomepost the topics of the presentation.
Bacthera And Capsugel Enprotect Capsule: From Complexity To Simplicity
Felix Faupel, Chief Commercial Officer at Bacthera, discussed how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market.
Latest related content
